HS3003
Import
Import of HS3003 to Japan, Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale.
HS2 description
Pharmaceutical products
Example charts for
HS3003
Click on the image to enlarge it.
Online, realtime, instant access to 20+ interactive charts for every HS code.
Identify trends, evaluate opportunities, build your Japan strategy with real time + historical data.
Japan import & export statistics for serious decision makers
Reduce your working hours with trade statistics data 95%.
HS4 description
Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale.
HS4 details
30.03 | Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. | |
3003.10 | 000 | Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives |
3003.20 | 000 | Other, containing antibiotics |
Other, containing hormones or other products of heading 29.37 : | ||
3003.31 | 000 | Containing insulin |
3003.39 | 000 | Other |
Other, containing alkaloids or derivatives thereof : | ||
3003.41 | 000 | Containing ephedrine or its salts |
3003.42 | 000 | Containing pseudoephedrine (INN) or its salts |
3003.43 | 000 | Containing norephedrine or its salts |
3003.49 | 000 | Other |
3003.60 | 000 | Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter |
3003.90 | 000 | Other |
Blog posts about
HS3003

Were you looking for export statistics for this particular HS number? Click the following link:
Memorize
anything






